We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $96.1B
1-Year Est. Return 40.06%
This Fund
S&P 500
This Quarter Est. Return
-14.67%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$39.6B
AUM Growth
-$8.6B
Cap. Flow
-$515M
Cap. Flow %
-1.3%
Top 10 Hldgs %
21.58%
Holding
2,991
New
339
Increased
842
Reduced
1,284
Closed
225

Top Sells

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$196M
2
ORLY icon
O'Reilly Automotive
ORLY
+$193M
3
ROST icon
Ross Stores
ROST
+$180M
4
LLY icon
Eli Lilly
LLY
+$164M
5
CDW icon
CDW
CDW
+$153M

Sector Composition

Rank Sector Weight
1 Technology 24.12%
2 Healthcare 14.61%
3 Financials 10.79%
4 Consumer Discretionary 10.65%
5 Industrials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRLD icon
2901
World Acceptance Corp
WRLD
$873M
-1,767
Closed -$339K
WTBA icon
2902
West Bancorporation
WTBA
$496M
-7,554
Closed -$206K
WVE icon
2903
Wave Life Sciences
WVE
$993M
-84,660
Closed -$169K
ZVRA icon
2904
Zevra Therapeutics
ZVRA
$673M
-10,899
Closed -$55K
QTTB icon
2905
Q32 Bio
QTTB
$459M
-3,200
Closed -$175K
RPT
2906
Rithm Property Trust
RPT
$98.2M
-5,379
Closed -$379K
TECX
2907
Tectonic Therapeutic
TECX
$623M
-1,135
Closed -$18K
NBIS
2908
Nebius Group N.V.
NBIS
$49.1B
$0 ﹤0.01%
34,476
NAGE
2909
Niagen Bioscience
NAGE
$244M
-17,907
Closed -$44K
SYRS
2910
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-3,974
Closed -$47K
VIRX
2911
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-12,841
Closed -$61K
GATO
2912
DELISTED
Gatos Silver, Inc.
GATO
-17,824
Closed -$77K
PSTX
2913
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-11,437
Closed -$51K
ITI
2914
DELISTED
Iteris, Inc.
ITI
-19,781
Closed -$59K
GRTS
2915
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-15,920
Closed -$66K
SEEL
2916
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
-9
Closed -$29K
EGRX
2917
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-4,774
Closed -$236K
GTHX
2918
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-14,906
Closed -$113K
ASXC
2919
DELISTED
Asensus Surgical, Inc.
ASXC
-89,407
Closed -$56K
NWLI
2920
DELISTED
National Western Life Group, Inc. Class A
NWLI
-1,006
Closed -$212K
DMTK
2921
DELISTED
DermTech, Inc. Common Stock
DMTK
-428,882
Closed -$6.3M
CAMP
2922
DELISTED
CalAmp Corp.
CAMP
-610
Closed -$103K
MRNS
2923
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-14,703
Closed -$137K
TRVN
2924
DELISTED
Trevena, Inc.
TRVN
-97
Closed -$33K
AWH
2925
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
-1,808
Closed -$28K

Similar funds

VOYA Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, VOYA Investment Management held 2,991 positions worth $39.6B, down 18% from $48.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

VOYA Investment Management's Q2 2022 filing shows 339 new, 842 increased, 1,284 reduced and 225 closed positions. Its largest new stake was iShares MSCI Japan ETF: 5,498,157 shares worth $290M. The largest sale was Zebra Technologies, an estimated $196M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • VOYA Investment Management's largest Q2 2022 buy was iShares MSCI Japan ETF: 5,498,157 shares worth $290M.
  • VOYA Investment Management added most to Visa in Q2 2022, an estimated $356M increase.
  • VOYA Investment Management's biggest Q2 2022 reduction was Zebra Technologies, cutting an estimated $196M.
  • VOYA Investment Management fully exited Canada Goose Holdings in Q2 2022, selling an estimated $11M.
  • VOYA Investment Management's ten largest holdings make up 22% of its $39.6B portfolio in Q2 2022.
  • VOYA Investment Management opened 339 new positions and closed 225 in Q2 2022.
  • VOYA Investment Management's portfolio value fell 18% quarter-over-quarter to $39.6B.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.